Insidersinvested$26.5mMino-Lokis our leadassetI won't diluteshareholdersWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamI/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsMyron Holubiakand I founded aprivatecompany in2013An actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfWe willhaveexclusivityWe expect tofinish theMino-Loktrial this yearI/ONTAKis our leadassetMino-WrapI/ONTAKwas thebest deal Iever madeWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023Insidersinvested$26.5mMino-Lokis our leadassetI won't diluteshareholdersWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamI/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsMyron Holubiakand I founded aprivatecompany in2013An actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfWe willhaveexclusivityWe expect tofinish theMino-Loktrial this yearI/ONTAKis our leadassetMino-WrapI/ONTAKwas thebest deal Iever madeWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Insiders invested $26.5m
  2. Mino-Lok is our lead asset
  3. I won't dilute shareholders
  4. We intend to submit a BLA in 2H 2022
  5. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  6. We had a phase 2b trial with 100% efficacy
  7. Hemorrhoids is a $2B market
  8. Only biotech with 2 Myron's on the leadership team
  9. I/ONTAK's potential market is >$300m
  10. Not many companies this size with 2 late stage assets
  11. Myron Holubiak and I founded a private company in 2013
  12. An actual iMSC update
  13. There are no FDA approved drugs to treat hemorrhoids
  14. Mino-Lok potential market >$1B
  15. Our Halo-Lido trial will have final patient by end of 2022
  16. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  17. I'm a shareholder myself
  18. We will have exclusivity
  19. We expect to finish the Mino-Lok trial this year
  20. I/ONTAK is our lead asset
  21. Mino-Wrap
  22. I/ONTAK was the best deal I ever made
  23. We will open up international sites for Mino-Lok trial
  24. We have enough cash to go well into 2023